Yu, Yi-Ru http://orcid.org/0000-0002-3562-3502
Imrichova, Hana http://orcid.org/0000-0003-0385-1823
Wang, Haiping
Chao, Tung
Xiao, Zhengtao http://orcid.org/0000-0002-5535-5381
Gao, Min http://orcid.org/0000-0003-2106-0267
Rincon-Restrepo, Marcela
Franco, Fabien
Genolet, Raphael
Cheng, Wan-Chen
Jandus, Camilla http://orcid.org/0000-0002-7405-5747
Coukos, George http://orcid.org/0000-0001-8813-7367
Jiang, Yi-Fan
Locasale, Jason W. http://orcid.org/0000-0002-7766-3502
Zippelius, Alfred http://orcid.org/0000-0003-1933-8178
Liu, Pu-Ste
Tang, Li http://orcid.org/0000-0002-6393-982X
Bock, Christoph http://orcid.org/0000-0001-6091-3088
Vannini, Nicola http://orcid.org/0000-0002-6351-7512
Ho, Ping-Chih http://orcid.org/0000-0003-3078-3774
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_182470)
Article History
Received: 25 January 2020
Accepted: 24 August 2020
First Online: 5 October 2020
Competing interests
: P.-C.H. is serving as a member of the scientific advisory board for Elixiron Immunotherapeutics and Acepodia and has received research grants from Elixiron Immunotherapeutics, Roche and Novartis. P.-C.H. received honoraria from Pfizer and Chugai.